HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leyi Lin Selected Research

Edema (Dropsy)

1/2022Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leyi Lin Research Topics

Disease

8Dengue (Dengue Fever)
10/2022 - 06/2017
2Infections
01/2021 - 01/2020
1Edema (Dropsy)
01/2022
1Zika Virus Infection
10/2018

Drug/Important Bio-Agent (IBA)

5Inactivated VaccinesIBA
10/2022 - 06/2017
3VaccinesIBA
10/2022 - 10/2018
2Dengue VaccinesIBA
01/2021 - 01/2020
1AntigensIBA
01/2022
1Virulence Factors (Pathogenicity Factors)IBA
01/2022
1Aluminum Hydroxide (Algeldrate)FDA Link
06/2017
1AS03 adjuvantIBA
06/2017
1aluminum sulfate (alum)IBA
06/2017

Therapy/Procedure

1Therapeutics
01/2021